Clinical Trials in New York

Showing 2261-2280 of 10,830 trials

A Study Assessing KB407 for the Treatment of Cystic Fibrosis

NCT05504837

This study will evaluate safety and tolerability of ascending doses of nebulized KB407 in adults with cystic fibrosis.

Krystal Biotech, Inc.12 participantsStarted Jun 2023

Gainesville, Florida, United States • Northfield, Illinois, United States • Hawthorne, New York, United States +2 more locations

COMPLETEDPhase 1< 1 mile

A Study of JNJ-64264681 in Participants With Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia

NCT04210219

The purpose of the study is to determine the recommended Phase 2 dose(s) (RP2D\[s\]) in B cell non-Hodgkin lymphoma (NHL) and chronic lymphocytic leukemia (CLL) in Part 1 and to evaluate the safety of JNJ-64264681 at the RP2D(s) in Part 2.

Lymphoma, Non-HodgkinLeukemia, Lymphocytic, Chronic, B-Cell

Janssen Research & Development, LLC85 participantsStarted Jul 2020

New York, New York, United States • Tbilisi, Georgia • Chisinau, Moldova +12 more locations

A Study Assessing KB407 for the Treatment of Cystic Fibrosis

A Study of JNJ-64264681 in Participants With Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia

Find Trials by Condition in New York

STICH3C Cardiac Magnetic Resonance Observational Study

Intermediate-size Expanded Access to ONC201 for Patients With H3 K27M-mutant and/or Midline Gliomas

Efficacy and Safety Study of Adjunctive Troriluzule in Obsessive Compulsive Disorder

Characterization of the Cardiac Phenotype of Friedreich's Ataxia (FRDA)

A Phase 2 Safety and Efficacy Study of INCB050465 in Subjects With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (CITADEL-202)

A Study of Tirzepatide (LY3298176) in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF) and Obesity: The SUMMIT Trial

Systemic Symptoms: Biospecimen Analysis Study

[177Lu]Lu-NeoB in Combination With Ribociclib and Fulvestrant in Participants With ER+, HER2- and GRPR+ Advanced Breast Cancer

An Efficacy, Safety, and Tolerability Study of VX-880 in Participants With Type 1 Diabetes With a Kidney Transplant

Families Left Behind

Study to Assess AFM24 in Combination With Atezolizumab in Selected Advanced/Metastatic EGFR-expressing Cancers

Defining the Genetic Etiology of Suppurative Lung Disease in Children and Adults

PTG-300 in Subjects With Hereditary Hemochromatosis

Characterizing the Upper Airway Manifestations in Primary Ciliary Dyskinesia and Primary Immunodeficiencies

The ReTAVI Prospective Observational Registry

Study to Assess the Efficacy and Safety of NTRA-2112 on Intestinal Malabsorption in Preterm Infants

A Study to Evaluate the Effect of Ustekinumab on Cytochrome P450 Enzyme Activities Following Induction and Maintenance Dosing in Participants With Active Crohn's Disease or Ulcerative Colitis

INCB050465 in Combination With Rituximab, Bendamustine and Rituximab, or Ibrutinib in Participants With Previously Treated B-Cell Lymphoma (CITADEL-112)